Altasciences

Dr. Lynne Le Sauteur and her team are in the spotlight in Insights Care’s The Top Most Innovative Bioanalytical Service Providers to Watch! Read how our experts are leading the charge in bioanalytical advancements: https://lnkd.in/dxGi48qz #Bioanalysis #DrugDevelopment #LifeSciences Lynne LeSauteur

Don't miss out! Watch this on-demand webinar on which we collaborated with Cambridge Cognition to learn about the important role of cognitive and pharmacodynamic testing in first-in-human (FIH) trials for novel CNS-active drugs:  https://lnkd.in/gVcMjVAv Key topics include: • selecting the right cognitive and pharmacodynamic tests for your CNS-active drug; • understanding the most relevant populations for testing; and • leveraging cognitive and pharmacodynamic data to shape your drug development and regulatory strategies. #DrugDevelopment #ClinicalTrials #CNS

The shortest distance from preclinical to clinical is Altasciences, a single provider for both phases—focused on early-phase drug development, including CDMO capabilities and bioanalytical labs. #DrugDevelopment #ClinicalTrials #Nonclinical

Preclinical manufacturing involves a series of sub-processes, all of which are critical to your overall drug development. In Issue 38 of The Altascientist, we explore critical considerations for formulation development and manufacturing for preclinical testing, and the strategies we employ to support your projects. Topics covered include:   - pre-formulation development  - biopharmaceutical assessments  - drug product manufacturing - quality control procedures - regulatory aspects - risk management Read the journal or listen to the audiobook: https://lnkd.in/ddAv99-F #DrugDevelopment #LifeScience #Nonclinical

How can you mitigate challenges that arise in your ophthalmic drug development program? By partnering with Altasciences, an integrated CRO/CDMO. We can safely advance your product seamlessly through each development phase with accelerated timelines and cost savings, ease of data transfer, reduced handoffs, and fewer logistical challenges. Learn how our end-to-end ophthalmic drug development solutions optimize your program and get your products to market, faster: https://lnkd.in/dfaXBFeN

We’re gearing up for the 4ᵗʰ Annual mRNA-Based Therapeutics Summit in Boston! Booth #34 As a leading CRO/CDMO, our services simplify your drug development journey to market. With a comprehensive understanding of FDA regulations and requirements for vaccine approval, and a large database of study participants, we are uniquely positioned to streamline the clinical development of new vaccines and delivery systems. Pre-book your preferred meeting time now: https://lnkd.in/d9CJy8Eh #mRNATherapeutics #Preclinical #Toxicology Meghan Lancaster Michael Olson

Watch as we take your fresh sample from our clinic to PBMC separation, all within just a few minutes. This two-minute video overviews our optimized workflows that ensure timely processing, transport, and analysis of your flow cytometry samples. Altasciences’ highly trained clinical staff and lab analysts understand the critical, time-sensitive nature of fresh sample handling –sample stability is our top priority, and we ensure safe, speedy, and regulatory-compliant handling.  #LifeSciences #DrugDevelopment #FlowCytometry

Watch as Altasciences’ panel of experts discuss the FDA’s guidelines for early-phase clinical development of psychedelics and the assessment of abuse potential: https://lnkd.in/gieVVqKc Topics covered: • important FDA recommendations; • clinical methods to optimize early-phase clinical trials with psychedelics; • how to address the abuse potential evaluation requirement for psychedelic drugs; and • strategies to ensure study integrity. #Psychedelics #DrugDevelopment #FDA

Conducting your early-phase clinical research in Canada for novel compounds provides significant advantages.   Altasciences’ Canadian clinical pharmacology unit offers 25 years of experience, and provides the quality data you need for faster, more informed go/no-go decisions.   Here’s how we will support you in Canada:   ✔ 265 beds with over 200 clinical trial experts ✔ Dedicated USP 797 certified research pharmacy licensed to handle narcotics (including Schedule I), precursors, and cannabis ✔ 15-minute drive to our bioanalytical laboratory for small/large molecule analysis, PD biomarkers, and flow cytometry ✔ Proven recruitment with a database of over 50,000 active participants  ✔ Access to special populations and patients for proof-of-concept (POC) arms ✔ Neuro/CNS specialization—human abuse potential (HAP), cognition, pain models, and CSF collections ✔ 12 on-site driving simulators with 13,000 simulated drives conducted ✔ 4 Principal Investigators—with GI, ophthalmology, and general practitioner background, supported by 12 Sub-Investigators ✔ Access to specialist physicians for protocol-specific needs ✔ Strong relationship with Health Canada with hundreds of clinical trial application submissions

The journey of your novel compound, pharmaceutical, or biologic is often overlooked in the initial setup discussions, leading to unforeseen delays. With Altasciences, you can expect a smooth journey with: •tailored plans for safe and efficient transportation of your samples; •flexible solutions aligned with International Trade Compliance standards; and •industry best practices to ensure secure and smooth transit of your valuable test materials. Our experience with sample distribution and logistics across different continents and countries spans decades. Contact us today to get advice you can count on! https://lnkd.in/gjQHxej #DrugDevelopment #LifeSciences #Biotech